Approved
consistent with changes and clarifications described in DoD memos
of 5-31-01 and 6-12-01. In any public discussion of the results of
these surveys DoD shall include a discussion of rates of response
and their effect on the results of the survey.
Inventory as of this Action
Requested
Previously Approved
06/30/2003
06/30/2003
900
0
0
300
0
0
0
0
0
Accordings to Section 701 of the
National Defense Authorization Act for Fiscal Year 2000, a
confidential survey will be conducted at two points in time: before
and after the implementation of the new Department of Defense
Uniform Formulary Program. The survey will be completed by
prescribers working with the direct care system (in military
treatment facilities) and the purchased care system (through
TRICARE contracts).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.